Big pharma company struggling for survival - Avis employé Director Merck

2,0
29 juin 2014
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Merck scientists, reputation in medicine

Inconvénients

excessive work hours, poor work-life balance, lots of bureaucracy; management doesn't care about employees. performance reviews are stack-ranked vs peers every year, to be eligible for top tiers employee must also be considered as having greatest "long-term growth potential" with the company relative to peers on the same job (good luck with that if you're over 50). high performers may end up in bottom 2 tiers (those individuals are then assigned low importance projects or laid off). Company has frequent layoffs due to poor planning and business failures. salary ranges for each job are frequently re-evaluated and individual salary reductions or capping are common (greated impact on long term, experienced employees who are usually at high end of the band). experienced level positions are eliminated (laid off) then reposted on the internet at lower salary or title.

Découvrez plus d’avis sur Merck

5,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent company to work with.

Inconvénients

No cons encountered so far

4,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Inconvénients

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Voir les avis par: Utile|Évaluation|Date|Tout